1. Home
  2. RMCF vs ACXP Comparison

RMCF vs ACXP Comparison

Compare RMCF & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocky Mountain Chocolate Factory Inc.

RMCF

Rocky Mountain Chocolate Factory Inc.

SELL

Current Price

$0.50

Market Cap

7.0M

ML Signal

SELL

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

SELL

Current Price

$1.04

Market Cap

5.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
RMCF
ACXP
Founded
1981
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0M
5.8M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
RMCF
ACXP
Price
$0.50
$1.04
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $10.33
AVG Volume (30 Days)
27.5K
★ 101.7K
Earning Date
10-19-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 34.88
N/A
EPS
★ N/A
N/A
Revenue
★ $30,432,352.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.59
$0.90
52 Week High
$2.99
$7.54

Technical Indicators

Market Signals
Indicator
RMCF
ACXP
Relative Strength Index (RSI) 21.89 47.37
Support Level N/A $0.95
Resistance Level $1.19 $1.12
Average True Range (ATR) 0.07 0.09
MACD -0.02 0.01
Stochastic Oscillator 0.00 67.29

Price Performance

Historical Comparison
RMCF
ACXP

About RMCF Rocky Mountain Chocolate Factory Inc.

Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The company prepares numerous products, including caramel apples in the store. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, and Others. The company derives maximum revenue through manufacturing activities. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

Share on Social Networks: